psa decision aid racgp

Fong K, Cancer Council Australia Lung Cancer Prevention and Diagnosis Guidelines Working Party. Everett T, Bryant A, Griffin MF, Martin-Hirsch PP, Forbes CA, Jepson RG. Burn J, Gerdes AM, Macrae F, et al. Cochrane Database Syst Rev 2013;(6):CD001877. Cancer Council Australia Colorectal Cancer Guidelines Working Party. Cochrane Database Syst Rev 2010;(11):CD002748. Here's another Patient Decision Aid on screening. Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and metaanalysis. Active smoking and breast cancer risk: Original cohort data and meta-analysis. Screening for lung cancer. Ann Intern Med 2011;155(11):762–71. National cancer prevention policy 2007−09. For male patients aged 50–69 years who request information and screening, consider PSA testing every two years after obtaining informed consent, Asymptomatic men at potentially higher risk due to family history, Recommend individualised discussion with patient based on assessment of risks and benefits, National Health and Medical Research Council (NHMRC), ‘. Advice and guidelines for GPs and practice teams to help protect general practice information systems, Video consultations can provide convenient and accessible healthcare delivery, Read all of the RACGP reports and submissions on various healthcare topics, Read all of the RACGP position statements on various healthcare topics. JAMA 2014;311(11):1143–49. Posted in News Release. Med J Aust 2006;185(9):490–95. Canberra: DoH, 2014. The AAFP does not recommend routine prostate-specific antigen (PSA)-based screening for prostate cancer. 2 What methods of decision support for men about PSA testing increase men’s capacity to make an informed decision for or against testing? Considering the inter-test and biological variation London: NICE, 2015. This decision aid is for men who are concerned about prostate cancer and are trying to decide whether or not to . Year of last update or review: 2015: Format: Web, paper: How to obtain: Click here to view the decision aid on the developer website: Developer: Mayo Clinic: Where was it developed? Preventive therapy for breast cancer: A consensus statement. Int J Cancer 2006;118(6):1481–95. Subscribe to RACGP Standards News to receive important Standards updates and our quarterly newsletter. This guideline is intended for health professionals working with middle-aged and older men who do not have any symptoms that suggest they might have prostate cancer and are considering having a prostate-specific antigen (PSA) test, or who decide to have a test after they have been informed of the benefits and harms of testing. Estimates of benefits and harms of prophylactic use of aspirin in the general population. Decison-making in HBV. Commonwealth Department of Health. Pap smear screening at an urban aboriginal health service: Report of a practice audit and an evaluation of recruitment strategies. Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P. Relative risk of prostate cancer for men with affected relatives: Systematic review and meta-analysis. Commonwealth Department of Health, Standing Committee on Screening. International Lung Screen Trial (ILST). Cancer 2003;97(8):1894–1903. National Cancer Institute. The Royal Australian College of General Practitioners acknowledges Aboriginal and Torres Strait Islander peoples as the Traditional Custodians of the land and sea in which we live and work, we recognise their continuing connection to land, sea and culture and pay our respects to Elders past, present and future. Christou A, Katzenellenbogen JM, Thompson SC. Clinical practice guidelines PSA testing and early management of test-detected prostate cancer. Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Commonwealth Department of Health. Australian burden of disease study: Impact and causes of illness and death in Aboriginal and Torres Strait Islander people 2011. Canberra: ABS and AIHW, 2008., 2016, Evidence base to a preventive health assessment in Aboriginal and Torres Strait Islander people, RACGP Aboriginal and Torres Strait Islander Health, RACGP practice owners national conference, Population-based screening is not recommended. Christou A, Thompson SC. How could the National bowel cancer screening program for Aboriginal people in Western Australia be improved? Australia’s national bowel cancer screening program: Does it work for Indigenous Australians? Lancet Oncol 2011;12(5):496–503. Australian General Practice Training (AGPT) Program, General Practice – Educational Framework, National Research and Evaluation Ethics Committee (NREEC), Pre-Employment Structured Clinical Interview (PESCI), General Practice Experience online application, Professional support over the general practice continuum, General Practice Mental Health Standards Collaboration, The Mental Health Professionals' Association, Supervising medical students and prevocational doctors, COVID-19 and general practice research projects, Delegate conditions and cancellation policy, More doctors for Rural Australia program (MDRAP), RACGP Practice Owners National Conference, Supervising medical students and prevocational doctors in general practice, GP Registrars in the Australian Defence Force (ADF), Applications to trial an alternative process, Aboriginal and Torres Strait Islander health, Guidelines for preventive activities in general practice, National guide to a preventive health assessment for Aboriginal and Torres Strait Islander people, Management of type 2 diabetes: A handbook for general practice, New items for COVID-19 telehealth and phone services, Guide to providing telephone and video consultations in general practice, Telephone and video consultations in general practice: Flowcharts, Video consultations with patients suspected to have COVID-19, Telehealth consultations using an interpreter, Telehealth and supervision: A guide for GPs in training and their supervisors, Consultations in the practice with patients suspected of having COVID-19, Responding to a COVID-19 case in the practice team, Optimising the use of personal protective equipment in general practice during COVID-19, Home-care guidelines for adult patients with mild COVID-19, Caring for adult patients with post-COVID-19 conditions, Guiding principles for the establishment and ongoing management of GP-led COVID-19 respiratory clini, Managing patients who present with respiratory symptoms, New items for additional mental health support for people affected by COVID-19, Managing mild COVID-19 at home with assistance from your GP, Patient resource: Managing post-COVID-19 symptoms, Having a phone or video consultation with your regular GP: Information and support for patients, Letter for employers seeking staff medical clearances, Providing care and support during disasters, Emergency planning and response factsheets, Drugs of dependence: Responding to requests, Guiding principles for clinical follow up systems in general practice software, A guide for ensuring good referral outcomes for your patients, National Disability Insurance Scheme: Information for general practitioners, RACGP Steriliser Record System - logbook and templates, General practice policy and procedure templates, Resources to help GPs support patients to access the NDIS, Preventive healthcare and the Medicare Benefits Schedule, Standards for general practices (5th edition), Standards for general practices (4th edition), Interpretive guide to the RACGP Standards, Standards for general practice residential aged care (1st edition), Standards for after-hours and medical deputising services, Standards for Patient-Centred Medical Homes, Infection prevention and control standards, Privacy and managing health information in general practice, Reducing the environmental impact of a general practice, Managing external requests for patient information, Minimum requirements for clinical information systems, Using personal mobile devices for clinical photos, Submission on the National Pancreatic Cancer Roadmap, Submission on the Health Insurance Amendment (Compliance Administration) Bill 2020, National Aboriginal and Torres Strait Islander Suicide Prevention Strategy, Submission to the Australian Commission on Quality and Safety in Health Care on its draft National S, Submission on changes to the Australian Immunisation Register Act (2015), Submission on the ACSQHC Acute Anaphylaxis Clinical Care Standard, Cancer Australia consultation - Investigating symptoms of lung cancer: a guide for health profession, Submission to the Opthalmology Clinical Committee of the MBS Review, Submission to the MBS Review – Consumer Panel Report, Submission to the Australian National Audit Office – Managing health provider compliance audit, Submission to the MBS Review – Report from the Otolaryngology, Head and Neck Surgery Clinical Commit, Submission to the MBS Review - Report from the Blood Products Working Group, Supplementary submission to the MBS Review - Cardiac Services Clinical Committee, Submission to the Senate Community Affairs References Committee effectiveness of the Aged Care Quali, Submission to the Joint Standing Committee on the National Disability Insurance Scheme – ICT contrac, Submission to Safe Work Australia on National Return to Work Strategy Discussion Paper, Overview of the 2018-19 Mid-Year Economic and Fiscal Outlook (MYEFO), The impact of climate change on human health, The role of general practice in the provision of healthcare to children and young adults, Access to COVID-19 prevention, screening and treatment - people with intellectual and developmental, Independent nurse-led clinics in primary care, Addressing social and cultural determinants in primary care, Identification of Aboriginal and Torres Strait Islander patients in general practice, Working together to improve the health and wellbeing of Aboriginal and Torres Strait Islander people, Support for increased investment in Aboriginal Community Controlled Health Organisations, A stronger primary health system for Aboriginal and Torres Strait Islander people, Principles on the role of the GP in supporting work participation, The regulatory framework for medicinal use of cannabis products, Member feedback on Federal Government changes to COVID-19 telehealth items, RACGP Standards for general practice residential aged care for second consultation, RACGP Standards for health services in Australian prisons (2nd edition), Royal Commission and Senate inquiry into the 2019/2020 bushfires, AIHW National Health Information Strategy - Draft Framework Consultation, MBS Review Taskforce: Several reports open for consultation November, Economic benefits of the Vision for general practice and a sustainable healthcare system, Chapter 15: Prevention and early detection of cancer, Preventing child maltreatment – Supporting families to optimise child safety and wellbeing, Bronchiectasis and chronic suppurative lung disease, Chapter 10: Acute rheumatic fever and rheumatic heart disease, Chapter 11: Cardiovascular disease prevention, Chapter 12: Type 2 diabetes prevention and early detection, Chapter 13: Chronic kidney disease prevention and management, Chapter 14: Sexual health and blood-borne viruses, Prevention and early detection of cervical cancer, Prevention and early detection of primary liver (hepatocellular) cancer, Prevention and early detection of breast cancer, Prevention and early detection of colorectal (bowel) cancer, PSA testing for prostate cancer in asymptomatic men: Information for health practitioners, National Cervical Screening Program: Guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding, About the human papillomavirus (HPV) and cervical cancer, UK National Screening Committee (UK NSC) recommendation on cervical cancer screening in women, Pharmaceutical Benefits Scheme: General statement for drugs for the treatment of hepatitis C, Position statement: Early detection of breast cancer, Position statement: Overdiagnosis from mammographic screening, Pharmaceutical Benefits Scheme: Raloxifene, Early detection of breast cancer: NBOCC position statement, Policy on screening women aged 40–49 years, Clinical practice guidelines for the prevention, early detection and management of colorectal cancer, Genetics of Prostate Cancer (PDQ®) – Health professional version, Clinical practice guidelines PSA testing and early management of test-detected prostate cancer, Prostate cancer screening position statement, Prostate cancer risk management programme (PCRMP): Benefits and risks of PSA testing. Epidemiology 2009;20(5):752–56. PSA is a protein made by the prostate. PSA Choice Decision Aid. Canberra: DoH, 2015. It is for: • healthy men with no signs or symptoms (known as asymptomatic) and with no close blood relative with the disease • aged 50–69 years • who are considering a prostate specific antigen (PSA) blood test to screen for prostate cancer. Commonwealth Department of Health. Aust Fam Physician 2008;37(3):178–82. Canberra: AIHW, 2017. The Royal Australian College of General Practitioners. If you have a positive PSA test result (a high PSA level) you will be referred to a specialist for further investigations and possibly for treatment of prostate cancer. Doctors should help such men to make a fully informed decision whether or not to commence regular PSA screening – DRE screening is no longer recommended. Definitive treatment is offered at a time when disease progression is detected and cure is deemed possible. Doctors should help such men to make a fully informed decision whether or not to commence regular PSA screening – DRE screening is no longer recommended. Liede A, Karlan BY, Narod SA. Cochrane Database Syst Rev 2011;(5):CD002834. Active surveillanceiientails close follow-up of patients diagnosed with low-risk prostate cancer. Make your own decision about whether to be tested after a discussion with your doctor. Bloodborne viral and sexually transmissible infections in Aboriginal and Torres Strait Islander people: Annual surveillance report 2016. Clinical practice guidelines for surveillance colonoscopy. 2: In men without evidence of prostate cancer does a decision support intervention or decision aid compared with usual care improve knowledge, decisional satisfaction, decision-related distress and We wish you a happy, safe and peaceful festive season. Breast cancer in Australia: An overview. World Cancer Research Fund and American Institute for Cancer Research. For a man with a PSA value above 3, repeat testing every 2 years should be recommended. Cervical cancer screening. Australian Institute of Health and Welfare. Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia. Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J. Lancet 2011;378(9809):2081–87. The current PSA president, Dr Chris Freeman, argues that a collaborative model, where pharmacists prescribe either with checks from a GP or while based in a GP clinic, may benefit both professions. Advice about familial aspects of breast cancer and epithelial ovarian cancer: A guide for health professionals. Sydney: Cancer Council Australia, 2011. Sydney: Cancer Council, 2015.

What Time Is The Debate Tonight In New York, Croyde Bay Covid, Midland, Texas Economy 2020, Pangako Silent Sanctuary Chords, Daniel Hughes Obituary Arkansas, Gold Loan Interview Questions And Answers, Business Adaptation Grant Iom,

Dodaj komentarz

Twój adres email nie zostanie opublikowany. Pola, których wypełnienie jest wymagane, są oznaczone symbolem *

Please wait...

Subscribe to our newsletter

Want to be notified when our article is published? Enter your email address and name below to be the first to know.